Leon J Menezes

Learn More
BACKGROUND Whether T1-mapping cardiovascular magnetic resonance (CMR) can accurately quantify the area-at-risk (AAR) as delineated by T2 mapping and assess myocardial salvage at 3T in reperfused ST-segment elevation myocardial infarction (STEMI) patients is not known and was investigated in this study. METHODS 18 STEMI patients underwent CMR at 3T(More)
PURPOSE To assess the diagnostic performance of PET/MR in patients with non-small-cell lung cancer. METHODS Fifty consecutive consenting patients who underwent routine (18)F-FDG PET/CT for potentially radically treatable lung cancer following a staging CT scan were recruited for PET/MR imaging on the same day. Two experienced readers, unaware of the(More)
  • 1